- Lobbying
- Lobbying by Huvepharma
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Susan Hirschmann | COS, Rep. Van Hilleary and Majority Whip Tom DeLay |
James Burchfield | Staff Associate, House Foreign Affairs Committee; Professional Staff Member, House Committee on Small Business; Senior Policy Advisor, Congressman Steve Chabot |
Cheryl Jaeger | Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. Cox |
Christopher Hatcher | Sch. C, Treasury; Associate Staff, House Rules Committee; LD, Rep. Scott McInnis |
Grant Barbosa | Legislative Assistant, Sen. Harris; Legislative Assistant, Rep. Sander M. Levin; Congressional Hispanic Caucus Institute Fellow, Rep. Xavier Becerra |
Matthew Hoekstra | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget
Registration
Issue(s) they said they’d lobby about: Animal drug research and development, animal drug manufacturing..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate